Phase I Study of BMS-214662 Oral Dosing in Patients With Advanced Malignancies
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2010
At a glance
- Drugs BMS 214662; BMS 214662
- Indications Colorectal cancer; Sarcoma; Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (Apr 2001) added as reported by ClinicalTrials.gov.
- 27 Sep 2005 New trial record.